Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart Failure
Graphical Abstract
Take-Home Visual Graphic: Changes in circulating angiokines are associated with reverse remodeling and outcomes in chronic heart failure.
Section snippets
Clinical Perspective
A decrease in cardiac capillary density has been associated with worsening heart failure. We identified associations between concentrations of proteins known to affect endothelial function with cardiac size and function in patients with HFrEF. Of measured factors, we found ANGPT2, VEGFR1 and HGF concentrations to be closely associated with ventricular remodeling and to be associated with future hospitalization and death due to HFrEF. Our work suggests that endothelial remodeling is an important
Lay Summary
Prior work has shown that failing hearts have a reduced density of blood vessels. We hypothesized that circulating proteins that regulate blood vessel growth and function might be altered in patients with heart failure. We measured protein levels in a group of patients from the GUIDE-IT study that had multiple assessments of heart size and function. We found that higher concentrations of ANGPT2, VEGFR1 and HGF in the blood are related to larger hearts with worse function. In hearts that
Methods
Trial design and outcomes for the GUIDE-IT study have been reported previously.29,30 Briefly, GUIDE-IT was a multicenter trial that randomized 894 patients with left ventricular ejection fraction (LVEF) ≤ 40% to NT-proBNP-guided management or usual care. A follow-up of 24 months after enrollment was planned; however, GUIDE-IT was stopped early because of futility. 268 participants from GUIDE-IT also participated in a prespecified echocardiographic substudy.31 These participants underwent
Patient Population
There were 99 participants from the GUIDE-IT Echo substudy who had available plasma for Angiome profiling. Cohort characteristics are presented in Table 1. The average age was 60.9 ± 11.2 years (mean ± SD); 29.3% (29/99) of patients were female; and 48.5% (48/99) of participants had ischemic cardiomyopathy. Mean LVEF at the time of enrollment was 28.2 ± 10.0%, with improvement in mean LVEF over 12 months to 34.5 ± 11.9%. Median follow-up was 18.7 months (IQR 15.0–23.8 months). Overall, 7.1%
Discussion
Much of the biology of reverse cardiac remodeling has focused on changes to the cardiomyocyte. For example, decreases in cardiomyocyte size, increased β-adrenergic receptor density and improved calcium handling have all been reported with reverse remodeling.38 Importantly, the fetal gene-expression program that is induced in failing myocytes is attenuated, likely reflected clinically by decreased NT-proBNP concentrations during reverse remodeling.31 Other work has suggested that restoration of
Conclusion
We found that circulating regulators of endothelial homeostasis and function have varying concentrations in patients with HfrEF and have dynamics that are closely associated with differences in cardiac structure and function. Of the factors assayed, ANGPT2, VEGFR1 and HGF concentrations were most robustly related to cardiac morphologic and functional parameters and were highly associated with the need for HHF and with death. Our work suggests that dynamic changes in circulating modulators of
Disclosures
JH completed work for this manuscript while supported by grant T32HL069749; DJM serves as a consultant for CVRx, Cytokinetics and Novonordisk and receives grant funding from NovoNordisk and the NIH; ABN receives funding from Genentech, HTG Molecular Diagnostics, MedImmune/AstraZeneca, Medpacto, Promega Corporation, and Seattle Genetics and consulting or personal fees from Eli Lilly, GSK, Promega Corporation, Leap Therapeutics, and Adjuvolt Therapeutics; ILP serves on the advisory board for
Author Contributions
RK, AN and GMF designed and conceptualized the study. RK and GMF obtained funding. Statistical analysis was performed by RK, JH and EY. The original manuscript was written and edited by RK, JH and GMF. Overall study supervision was provided by RK and GMF.
Acknowledgments
We thank all the patients and sites who generously participated in the GUIDE-IT study. We also thank Christopher Kontos and Michael Dee Gunn for helpful comments and discussion; Gayle Passmore for regulatory assistance; Andrew Shepple for assistance with sample transfer; and Mark Starr and Chris Brady for technical assistance.
Funding Sources
This work was funded by a grant from the Translating Duke Health Initiative (RK, GMF), a Duke University Strong Start Physician Scientist Award (RK), the Walker P. Inman Endowment (RK), NHLBI R01 HL146849 (RK), and NHLBI R01 HL157277 (RK). GUIDE-IT was funded by the NHLBI, and the embedded biorepository and echo substudies used for these analyses were funded by Roche Diagnostics (Rotkreutz, Switzerland).
References (54)
- et al.
Heart failure with recovered ejection fraction: a distinct clinical entity
J Cardiac Fail
(2011) - et al.
Dynamics of Cell generation and turnover in the human heart
Cell
(2015) - et al.
Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart
J Am Coll Cardiol
(2010) - et al.
Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy
J Am Coll Cardiol
(2008) - et al.
Angiotensin-converting enzyme inhibition promotes coronary angiogenesis in the failing heart of Dahl salt-sensitive hypertensive rats
J Card Fail
(2011) - et al.
Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
Redox Biol
(2018) - et al.
Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure
J Am Coll Cardiol
(2004) - et al.
Rationale and design of the GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) study
JACC Heart Fail
(2014) - et al.
NT-proBNP goal achievement is associated with significant reverse remodeling and improved clinical outcomes in HFrEF
JACC Heart Fail
(2019) - et al.
The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: Results of the REVERSE study
Heart Rhythm
(2015)
Associations of angiopoietins with heart failure incidence and severity
J Card Fail
Serum hepatocyte growth factor levels are increased in patients with congestive heart failure
J Card Fail
Prognostic value of angiopoietin-2 in patients with chronic heart failure
Int J Cardiol
The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure
J Am Coll Cardiol
Biomarker predictors of cardiac hospitalization in chronic heart failure: a recurrent event analysis
J Card Fail
Characteristics and outcomes of adult outpatients with heart failure and improved or recovered ejection fraction
JAMA Cardiol
Heart failure with recovered ejection fraction
J Echocardiogr
Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes
Circulation
Heterogeneous Outcomes of heart failure with better ejection fraction
J Cardiovasc Transl Res
Heart failure with improved ejection fraction: clinical characteristics, correlates of recovery, and survival: results from the Valsartan Heart Failure Trial
Circ Heart Fail
PROVE-HF investigators. Association of change in N-terminal pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction
JAMA
Endothelial-cardiomyocyte interactions in cardiac development and repair
Ann Rev Physiol
Endothelial contributions to zebrafish heart regeneration
J Cardiovasc Dev Dis
Cardiomyocyte: endothelial cell interactions in cardiac remodeling and regeneration
Front Cardiovasc Med
Coupled myovascular expansion directs cardiac growth and regeneration
Development
Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction
J Clin Invest
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure
J Clin Invest
Cited by (1)
Angiogenesis Markers and Reverse Remodeling in Patients With HFrEF
2023, Journal of Cardiac Failure